Who should receive an implantable cardioverter-defibrillator after myocardial infarction?

被引：0
作者：
Hutchinson M.D. [1 ]
Mountantonakis S. [1 ]
机构：
[1] Department of Medicine, Cardiovascular Division, University of Pennsylvania, Philadelphia, PA 19104
来源：
Current Heart Failure Reports | 2009年 / 6卷 / 4期
关键词：
Heart Rate Variability; Sudden Cardiac Death; Sudden Cardiac Death Risk; Cardiac Arrest Study; Cardiac Arrest Study Hamburg;
D O I：
10.1007/s11897-009-0033-5
中图分类号：
学科分类号：
摘要：
Despite a decline in overall cardiovascular mortality, the incidence of sudden cardiac death (SCD) continues to rise. Patients who survive a myocardial infarction (MI) with depressed ejection fraction are at particularly high risk for SCD. The development of implantable cardioverter-defibrillators (ICDs) has revolutionized SCD prevention; however, despite the current fervor for device implantation, many unresolved questions remain about risk stratification in post-MI patients. This review presents the current indications and timing of ICD implantation for primary and secondary prevention of SCD after MI. Several conventional and investigational methods of risk stratification after MI, as well as current controversies regarding device implantation in specific patient populations, are also reviewed. © 2009 Springer Science+Business Media, LLC.
引用
收藏
页码：236 / 244
页数：8
相关论文
共 51 条
  • [1] Myerburg R.J., Kessler K.M., Castellanos A., Sudden cardiac death: Epidemiology, transient risk, and intervention assessment, Ann Intern Med, 119, pp. 1187-1197, (1993)
  • [2] De Vreede-Swagemakers J.J., Gorgels A.P.M., Dubois-Arbouw W.I., Van Ree J.W., Daemen M.J.A.P., Houben L.G.E., Wellens H.J.J., Out-of-hospital cardiac arrest in the 1990s: A population-based study in the Maastricht area on incidence, characteristics and survival, Journal of the American College of Cardiology, 30, 6, pp. 1500-1505, (1997)
  • [3] Solomon S.D., Zelenkofske S., McMurray J.J.V., Finn P.V., Velazquez E., Ertl G., Harsanyi A., Rouleau J.L., Maggioni A., Kober L., White H., Van De Werf F., Pieper K., Califf R.M., Pfeffer M.A., Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both, New England Journal of Medicine, 352, 25, pp. 2581-2588, (2005)
  • [4] A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. the antiarrhythmics versus implantable defibrillators (AVID) investigators, N Engl J Med, 337, pp. 1576-1583, (1997)
  • [5] Kuck K.H., Cappato R., Siebels J., Et al., Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH), Circulation, 102, pp. 748-754, (2000)
  • [6] Connolly S.J., Gent M., Roberts R.S., Et al., Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone, Circulation, 101, pp. 1297-1302, (2000)
  • [7] Connolly S.J., Hallstrom A.P., Cappato R., Schron E.B., Kuck K.-H., Zipes D.P., Greene H.L., Boczor S., Domanski M., Follmann D., Gent M., Roberts R.S., Metal-analysis of the implantable cardioverter defibrillator secondary prevention trials, European Heart Journal, 21, 24, pp. 2071-2078, (2000)
  • [8] Raitt M.H., Renfroe E.G., Epstein A.E., Et al., stable" ventricular tachycardia is not a benign rhythm: Insights from the antiarrhythmics versus implantable defibrillators (AVID) registry, Circulation, 103, pp. 244-252, (2001)
  • [9] Bigger Jr J.T., Fleiss J.L., Kleiger R., Et al., The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction, Circulation, 69, pp. 250-258, (1984)
  • [10] Echt D.S., Liebson P.R., Mitchell L.B., Et al., Mortality and morbidity in patients receiving encainide, flecainide, or placebo. the Cardiac Arrhythmia Suppression Trial, N Engl J Med, 324, pp. 781-788, (1991)
123456